Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

901 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox.
Mazzotta V, Cozzi-Lepri A, Lanini S, Mondi A, Carletti F, Tavelli A, Gagliardini R, Vita S, Pinnetti C, Aguglia C, Colavita F, Faccendini P, Matusali G, Faraglia F, Beccacece A, Paulicelli J, Girardi E, Nicastri E, Vaia F, Maggi F, Antinori A. Mazzotta V, et al. Among authors: antinori a. J Med Virol. 2023 Jun;95(6):e28868. doi: 10.1002/jmv.28868. J Med Virol. 2023. PMID: 37306318 Clinical Trial.
Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02).
Amendola A, Bordi L, Angeletti C, Visco-Comandini U, Abbate I, Cappiello G, Budabbus MA, Eljhawi OA, Mehabresh MI, Girardi E, Antinori A, Ippolito G, Capobianchi MR. Amendola A, et al. Among authors: antinori a. J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):488-94. doi: 10.1097/00126334-200212150-00006. J Acquir Immune Defic Syndr. 2002. PMID: 12473837
Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure.
Zaccarelli M, Lorenzini P, Tozzi V, Forbici F, Ceccherini-Silberstein F, Gori C, D'Arrigo R, Trotta MP, Narciso P, Perno CF, Antinori A; Collaborative Group for Clinical Use of the HIV Genotype Resistance Test (GRT) at the National Institute for Infectious Diseases "Lazzaro Spallanzani". Zaccarelli M, et al. Among authors: antinori a. Infection. 2009 Jun;37(3):203-9. doi: 10.1007/s15010-008-8142-8. Epub 2009 Mar 9. Infection. 2009. PMID: 19274429
Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures.
Trotta MP, Cozzi-Lepri A, Ammassari A, Vecchiet J, Cassola G, Caramello P, Vullo V, Soscia F, Chiodera A, Ladisa N, Abeli C, Cauda R, Buonuomi AR, Antinori A, d'Arminio Monforte A; ICONA Foundation Study. Trotta MP, et al. Among authors: antinori a. Clin Infect Dis. 2010 Aug 15;51(4):456-64. doi: 10.1086/655151. Clin Infect Dis. 2010. PMID: 20597690
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count.
Marchetti G, Cozzi-Lepri A, Merlini E, Bellistrì GM, Castagna A, Galli M, Verucchi G, Antinori A, Costantini A, Giacometti A, di Caro A, D'arminio Monforte A; ICONA Foundation Study Group. Marchetti G, et al. Among authors: antinori a. AIDS. 2011 Jul 17;25(11):1385-94. doi: 10.1097/QAD.0b013e3283471d10. AIDS. 2011. PMID: 21505312
Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: prevalence and clinical outcome.
d'Arminio Monforte A, Cozzi-Lepri A, Girardi E, Castagna A, Mussini C, Di Giambenedetto S, Galli M, Cassola G, Vullo V, Quiros-Roldan E, Lo Caputo S, Antinori A; Icona Foundation Study Group. d'Arminio Monforte A, et al. Among authors: antinori a. Antivir Ther. 2011;16(7):1103-12. doi: 10.3851/IMP1883. Antivir Ther. 2011. PMID: 22024526
Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.
Cingolani A, Cozzi Lepri A, Castagna A, Goletti D, De Luca A, Scarpellini P, Fanti I, Antinori A, d'Arminio Monforte A, Girardi E. Cingolani A, et al. Among authors: antinori a. Clin Infect Dis. 2012 Mar;54(6):853-61. doi: 10.1093/cid/cir900. Epub 2011 Dec 12. Clin Infect Dis. 2012. PMID: 22157323
HIV-Infected Late Presenter Patients.
D'Arminio Monforte A, Antinori A, Girardi E, Ceccherini-Silberstein F, Marchetti G, Sabin CA, Montaner JS. D'Arminio Monforte A, et al. Among authors: antinori a. AIDS Res Treat. 2012;2012:902679. doi: 10.1155/2012/902679. Epub 2011 Nov 29. AIDS Res Treat. 2012. PMID: 22191018 Free PMC article. No abstract available.
Determinants of access to experimental antiretroviral drugs in an Italian cohort of patients with HIV: a multilevel analysis.
Girardi E, Scognamiglio P, Angeletti C, Gori A, Buonfrate D, Arlotti M, Mazzarello G, Castagna A, Andreoni M, d'Arminio Monforte A, Antinori A, Ippolito G; I.Co.Na Foundation Study. Girardi E, et al. Among authors: antinori a. BMC Health Serv Res. 2012 Feb 15;12:38. doi: 10.1186/1472-6963-12-38. BMC Health Serv Res. 2012. PMID: 22336471 Free PMC article.
901 results